Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytoma, Malignant Fibrous × regorafenib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan Syndrome 6 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Insulinoma 1 Glucagonoma 1

Interventions

Doxorubicin 5 pazopanib 3 Ifosfamide 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 tremelimumab 1 temsirolimus 1 sintilimab 1 saracatinib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sorafenib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Nivolumab 1 Neoadjuvant Therapy 1 Methotrexate 1 MLN 8237 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡